<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02137486</url>
  </required_header>
  <id_info>
    <org_study_id>TCHIRB-1030209-E</org_study_id>
    <nct_id>NCT02137486</nct_id>
  </id_info>
  <brief_title>Outcome of Coronary High Angulated Bifurcation Lesions Treated With Kissing Ballooning or Sequential Ballooning Techniques</brief_title>
  <acronym>MV:main branch</acronym>
  <official_title>Outcome of Coronary High Angulated Bifurcation Lesions Treated With Kissing Ballooning or Sequential Ballooning Techniques</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei City Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei City Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coronary artery bifurcation lesions prone to occur with the worsening of atherosclerosis.
      Their structural properties make angioplasty technique to increase the difficulty of
      implementation, but also increased the risks of the in-stent thrombosis and restenosis.
      Standard treatment of coronary bifurcation lesions remains controversial manner, especially
      when the side branch (SB) was large combined with high angulated bifurcation lesions. Complex
      procedures and certain types of lesions are associated with poor prognosis. There is no
      standard treatment for such lesions even with the development of drug-eluting stents solve
      partial problems. The investigators reviewed patients who received coronary intervention
      between 2009-2012 years and met the inclusion criteria, and then analyzed the prognostic
      relevance of these cases the use of different treatment modalities.

      We introduced a retrospective analysis for high angulated bifurcation lesions treated with
      either DES or BMS.

      Primary endpoint: cardiovascular mortality, TLR, MACE. secondary endpoint: procedure time,
      fluoroscopy time, procedure success, angiographic success.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2015</start_date>
  <completion_date type="Actual">November 1, 2017</completion_date>
  <primary_completion_date type="Actual">June 1, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Participants With Major Adverse Cardiac Events(MACE)</measure>
    <time_frame>periprocedure up to 12 months</time_frame>
    <description>Percentage of Participants with major adverse cardiac events(MACE) was defined as rates of target lesion revascularization (TLR) and restenosis during first post-treatment year, and rates of acute, subacute, and late in-stent thrombosis, periprocedure MI(myocardial infarction).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants With Cardiovascular Mortality(%)</measure>
    <time_frame>periprocedure up to 12 months</time_frame>
    <description>Percentage of Participants with cardiovascular mortality was defined as death related to cardiovascular causes within 2 years.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Angiographic Success(%)</measure>
    <time_frame>periprocedure up to 12 months.</time_frame>
    <description>Percentage of Participants with angiographic success was defined as residual stenosis&lt;50% under fluoroscopy at the end of procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Target Vessel Revascularization Rate</measure>
    <time_frame>periprocedure up to 12 months.</time_frame>
    <description>Percentage of Participants with target vessel revascularization rate, both arms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluoroscopy Time(Minutes) of Each Participants</measure>
    <time_frame>periprocedure up to 12 months.</time_frame>
    <description>as medical chart record.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure Time(Minutes) of Each Participants</measure>
    <time_frame>periprocedure up to 12 months.</time_frame>
    <description>as medical chart record.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">214</enrollment>
  <condition>Stable Angina</condition>
  <arm_group>
    <arm_group_label>sequential ballooning</arm_group_label>
    <description>include BMS or DES</description>
  </arm_group>
  <arm_group>
    <arm_group_label>final kissing ballooning</arm_group_label>
    <description>include BMS or DES</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients revceived coronary intervention between 2009-2014/3.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Angulated bifurcation:MV(main branch) and SB(side branch) angle&gt;70 degree. MV
             diameterâ‰¥2.5mm and eligible for stenting. lesion stenotic severity&gt;70% by
             QCA(Quantitative coronary analysis). 1 stent strategy. SYNTAX&gt;22 Procedure success. de
             novo lesion

        Exclusion Criteria:

          -  Bifurcation lesions intervention without side br. ballooning after stents deployment
             or procedure incomplete. Left main coronary artery bifurcational lesions.
             Elective,provisional or bail-out stenting for side br.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Taipei city hospital</name>
      <address>
        <city>Taipei</city>
        <zip>52005</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <study_first_submitted>April 19, 2014</study_first_submitted>
  <study_first_submitted_qc>May 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2014</study_first_posted>
  <results_first_submitted>November 10, 2017</results_first_submitted>
  <results_first_submitted_qc>September 13, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">October 4, 2019</results_first_posted>
  <last_update_submitted>September 13, 2019</last_update_submitted>
  <last_update_submitted_qc>September 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Taipei City Hospital</investigator_affiliation>
    <investigator_full_name>Yueh-Chung, Chen</investigator_full_name>
    <investigator_title>chief of ICU</investigator_title>
  </responsible_party>
  <keyword>stable angina</keyword>
  <keyword>high angulated bifurcation</keyword>
  <keyword>SYNTAX</keyword>
  <keyword>DES</keyword>
  <keyword>BMS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angina, Stable</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Sequential Ballooning</title>
          <description>the stent is placed in the MV and dilated, and then a second balloon just proximal to the opening of the SB is dilated in order to widen the diameter of the MV at the SV opening to allow more blood to be diverted into the SB; then treated with drug eluting stent or bare metal stent.</description>
        </group>
        <group group_id="P2">
          <title>Final Kissing Ballooning</title>
          <description>a balloon that extends from a position in the MV just proximal to the SB into a portion of the SB is inflated at the same time as the MV balloon; then treated with drug eluting stent or bare metal stent.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="112"/>
                <participants group_id="P2" count="102"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="112"/>
                <participants group_id="P2" count="102"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>high angle bifurcation lesion</population>
      <group_list>
        <group group_id="B1">
          <title>Sequential Ballooning</title>
          <description>treated with drug eluting stent or bare metal stent.</description>
        </group>
        <group group_id="B2">
          <title>Final Kissing Ballooning</title>
          <description>treated with drug eluting stent or bare metal stent.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="112"/>
            <count group_id="B2" value="102"/>
            <count group_id="B3" value="214"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="82"/>
                    <measurement group_id="B2" value="78"/>
                    <measurement group_id="B3" value="160"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68.69" spread="11.43"/>
                    <measurement group_id="B2" value="67.67" spread="11.49"/>
                    <measurement group_id="B3" value="67.98" spread="11.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="87"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="168"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Taiwan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="112"/>
                    <measurement group_id="B2" value="102"/>
                    <measurement group_id="B3" value="214"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants With Major Adverse Cardiac Events(MACE)</title>
        <description>Percentage of Participants with major adverse cardiac events(MACE) was defined as rates of target lesion revascularization (TLR) and restenosis during first post-treatment year, and rates of acute, subacute, and late in-stent thrombosis, periprocedure MI(myocardial infarction).</description>
        <time_frame>periprocedure up to 12 months</time_frame>
        <population>100%x2/112; 100%x7/102</population>
        <group_list>
          <group group_id="O1">
            <title>Sequential Ballooning</title>
            <description>treated with drug eluting stent or bare metal stent.</description>
          </group>
          <group group_id="O2">
            <title>Final Kissing Ballooning</title>
            <description>treated with drug eluting stent or bare metal stent.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Major Adverse Cardiac Events(MACE)</title>
          <description>Percentage of Participants with major adverse cardiac events(MACE) was defined as rates of target lesion revascularization (TLR) and restenosis during first post-treatment year, and rates of acute, subacute, and late in-stent thrombosis, periprocedure MI(myocardial infarction).</description>
          <population>100%x2/112; 100%x7/102</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="102"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.72" lower_limit="1.24" upper_limit="1.98"/>
                    <measurement group_id="O2" value="6.86" lower_limit="6.01" upper_limit="7.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants With Cardiovascular Mortality(%)</title>
        <description>Percentage of Participants with cardiovascular mortality was defined as death related to cardiovascular causes within 2 years.</description>
        <time_frame>periprocedure up to 12 months</time_frame>
        <population>100%x0/112; 100%x1/102</population>
        <group_list>
          <group group_id="O1">
            <title>Sequential Ballooning</title>
            <description>the stent is placed in the MV and dilated, and then a second balloon just proximal to the opening of the SB is dilated in order to widen the diameter of the MV at the SV opening to allow more blood to be diverted into the SB; then treated with drug eluting stent or bare metal stent.</description>
          </group>
          <group group_id="O2">
            <title>Final Kissing Ballooning</title>
            <description>a balloon that extends from a position in the MV just proximal to the SB into a portion of the SB is inflated at the same time as the MV balloon; then treated with drug eluting stent or bare metal stent.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Cardiovascular Mortality(%)</title>
          <description>Percentage of Participants with cardiovascular mortality was defined as death related to cardiovascular causes within 2 years.</description>
          <population>100%x0/112; 100%x1/102</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="102"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Angiographic Success(%)</title>
        <description>Percentage of Participants with angiographic success was defined as residual stenosis&lt;50% under fluoroscopy at the end of procedure.</description>
        <time_frame>periprocedure up to 12 months.</time_frame>
        <population>lesions of participants; 100%x90/112; 100%x84/102.</population>
        <group_list>
          <group group_id="O1">
            <title>Sequential Ballooning</title>
            <description>the stent is placed in the MV and dilated, and then a second balloon just proximal to the opening of the SB is dilated in order to widen the diameter of the MV at the SV opening to allow more blood to be diverted into the SB; then treated with drug eluting stent or bare metal stent.</description>
          </group>
          <group group_id="O2">
            <title>Final Kissing Ballooning</title>
            <description>a balloon that extends from a position in the MV just proximal to the SB into a portion of the SB is inflated at the same time as the MV balloon; then treated with drug eluting stent or bare metal stent.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Angiographic Success(%)</title>
          <description>Percentage of Participants with angiographic success was defined as residual stenosis&lt;50% under fluoroscopy at the end of procedure.</description>
          <population>lesions of participants; 100%x90/112; 100%x84/102.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="102"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90"/>
                    <measurement group_id="O2" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Target Vessel Revascularization Rate</title>
        <description>Percentage of Participants with target vessel revascularization rate, both arms</description>
        <time_frame>periprocedure up to 12 months.</time_frame>
        <population>Percentage of Participants with target vessel revascularization rate, both arms</population>
        <group_list>
          <group group_id="O1">
            <title>Sequential Ballooning</title>
            <description>include BMS or DES</description>
          </group>
          <group group_id="O2">
            <title>Final Kissing Ballooning</title>
            <description>include BMS or DES</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Target Vessel Revascularization Rate</title>
          <description>Percentage of Participants with target vessel revascularization rate, both arms</description>
          <population>Percentage of Participants with target vessel revascularization rate, both arms</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="102"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fluoroscopy Time(Minutes) of Each Participants</title>
        <description>as medical chart record.</description>
        <time_frame>periprocedure up to 12 months.</time_frame>
        <population>fluoroscopy time(minutes) of each participants</population>
        <group_list>
          <group group_id="O1">
            <title>Sequential Ballooning</title>
            <description>the stent is placed in the MV and dilated, and then a second balloon just proximal to the opening of the SB is dilated in order to widen the diameter of the MV at the SV opening to allow more blood to be diverted into the SB; then treated with drug eluting stent or bare metal stent.</description>
          </group>
          <group group_id="O2">
            <title>Final Kissing Ballooning</title>
            <description>a balloon that extends from a position in the MV just proximal to the SB into a portion of the SB is inflated at the same time as the MV balloon; then treated with drug eluting stent or bare metal stent.</description>
          </group>
        </group_list>
        <measure>
          <title>Fluoroscopy Time(Minutes) of Each Participants</title>
          <description>as medical chart record.</description>
          <population>fluoroscopy time(minutes) of each participants</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="102"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24" spread="6"/>
                    <measurement group_id="O2" value="36" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedure Time(Minutes) of Each Participants</title>
        <description>as medical chart record.</description>
        <time_frame>periprocedure up to 12 months.</time_frame>
        <population>procedure time(minutes) of each participants</population>
        <group_list>
          <group group_id="O1">
            <title>Sequential Ballooning</title>
            <description>the stent is placed in the MV and dilated, and then a second balloon just proximal to the opening of the SB is dilated in order to widen the diameter of the MV at the SV opening to allow more blood to be diverted into the SB; then treated with drug eluting stent or bare metal stent.</description>
          </group>
          <group group_id="O2">
            <title>Final Kissing Ballooning</title>
            <description>a balloon that extends from a position in the MV just proximal to the SB into a portion of the SB is inflated at the same time as the MV balloon; then treated with drug eluting stent or bare metal stent.</description>
          </group>
        </group_list>
        <measure>
          <title>Procedure Time(Minutes) of Each Participants</title>
          <description>as medical chart record.</description>
          <population>procedure time(minutes) of each participants</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="102"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84" spread="8"/>
                    <measurement group_id="O2" value="92" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Sequential Ballooning</title>
          <description>treated with drug eluting stent or bare metal stent.</description>
        </group>
        <group group_id="E2">
          <title>Final Kissing Ballooning</title>
          <description>treated with drug eluting stent or bare metal stent.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="112"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="102"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="112"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="102"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="112"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="102"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>taipei city hospital Ren-Ai branch</name_or_title>
      <organization>cardiovascular section</organization>
      <phone>0088627093600 ext 3741</phone>
      <email>chenyuehchung.tw@yahoo.com.tw</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

